Joint 3i/U2M2 project grants open pathways for infectious disease research University of Utah Health | May 6, 2021
Share this:
The University of Utah Health Immunology, Inflammation and Infectious Disease Initiative (3i), in conjunction with the University of Utah Molecular Medicine program (U2M2), has awarded program planning grants to four collaborative research projects. The funded projects will explore alternative treatments and diagnoses for many human disorders, including viral infections and sepsis.
“The Program Planning Grants are the natural next step from our previous grants aimed at building new collaborative teams,” says Ryan O’Connell, Ph.D., director of the 3i Initiative and an associate professor in Pathology at U of U Health. These previously funded teams and other groups fortified by new faculty recruits have matured to compete for large multi-PI grants. This program gives these teams the added resources needed to earn a fundable score by